Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Mycobacterium tuberculosis and the response of its host
-
2. The pathogenesis of tuberculosis
- Dr. William R. Bishai
-
3. Immune response and rational development of vaccines and biomarkers
- Prof. Dr. Stefan H. E. Kaufmann
-
4. Molecular mechanisms of drug resistance in M. tuberculosis
- Dr. Daniela Cirillo
- The epidemiology of tuberculosis
-
5. The basic epidemiology of tuberculosis (TB)
- Dr. David Dowdy
-
6. Global epidemiology of TB
- Dr. Philippe Glaziou
-
7. Social determinants of tuberculosis
- Dr. Knut Lönnroth
- The control of tuberculosis
-
8. Treatment of tuberculosis
- Dr. Jean-Pierre Zellweger
-
9. The End TB Strategy towards TB elimination 1
- Dr. Mario Raviglione
-
10. The End TB Strategy towards TB elimination 2
- Dr. Mario Raviglione
-
11. Financing TB care and control
- Dr. Christopher Fitzpatrick
- Dr. Andrea Pantoja
-
12. Tuberculosis and COVID-19
- Prof. Giovanni Battista Migliori
-
13. Multidrug resistant tuberculosis (MDR-TB): an update
- Dr. Simon Tiberi
-
14. Impact of HIV on tuberculosis in the developing world and how to manage it
- Prof. Anthony D. Harries
-
16. TB in children
- Prof. Ben J. Marais
-
17. Community engagement in tuberculosis care
- Ms. Lana Syed
-
18. India: the epicentre of global TB control
- Dr. Madhukar Pai
-
19. Community engagement in TB care
- Dr. Haileyesus Getahun
- Research and development for new approaches in the control of tuberculosis
-
20. Development of new regimens for tuberculosis
- Dr. Zhenkun Ma
-
22. Pharmacometrics in tuberculosis
- Prof. Charles A. Peloquin
-
23. Extrapulmonary tuberculosis
- Dr. Scott Heysell
-
24. The role of surgery in tuberculosis management
- Dr. Richard Zaleskis
- Archived Lectures *These may not cover the latest advances in the field
-
25. The development of current treatments for tuberculosis
- Dr. Andrew Nunn
-
26. The pathogenesis of tuberculosis
- Dr. William R. Bishai
-
27. Basics of tuberculosis epidemiology
- Prof. Frank Cobelens
-
29. The international approach to the control of tuberculosis
- Dr. Mario Raviglione
-
30. Public-private mix for TB care and control
- Dr. Mukund Uplekar
Printable Handouts
Navigable Slide Index
- Introduction
- Outline
- Representative case example from rural Tanzania
- Case
- Diagnosis
- Pathophysiology (briefly) of extrapulmonary TB
- Pathogenesis of extrapulmonary TB
- Categories of extrapulmonary TB
- Epidemiology of extrapulmonary TB
- Global burden of extrapulmonary TB
- 15-30% of all TB is extrapulmonary
- Diagnostic considerations
- Atypical presentation and diagnostic delay
- HIV drives TB incidence
- HIV and TB
- Extrapulmonary TB and the HIV epidemic
- The effect of HIV treatment on TB
- Anti-TNF-α therapy increases TB infection
- When to suspect extrapulmonary TB
- Diagnosing TB: Xpert
- Clinical presentations
- Lymphadenitis (scrofula)
- Bone and joint
- Gastrointestinal
- Genitourinary
- TB meningitis/CNS disease
- 'Military' TB (progressive hematogenous TB)
- A common cause of sepsis in HIV patients
- Many other extrapulmonary presentations
- Therapeutic considerations
- Relapse and atypical responses to treatment
- General observations on treatment
- Summary
- Thank you
Topics Covered
- Clinical case of TB from Tanzania
- Pathophysiology of extrapulmonary TB
- The epidemiology of extrapulmonary TB
- Diagnostic considerations
- Relationship between HIV and TB
- Clinical manifestations of TB disease
- Therapeutic considerations
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Heysell, S. (2022, April 27). Extrapulmonary tuberculosis [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/ZHXF9487.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Scott Heysell has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Respiratory Diseases
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, my name is Scott Heysell.
I'm an Associate
Professor of Medicine,
Infectious Diseases and
International Health
at the University of Virginia.
I'm also a Tuberculosis
Consultant for VDH.
I have the privilege to care
for people with TB here,
as well as with partners
abroad in TB endemic areas.
The topic today is
extrapulmonary tuberculosis,
a common manifestation of TB.
0:25
The outline for my talk begins with
a clinical case from rural Tanzania.
We'll talk briefly about
the pathophysiology of
extrapulmonary TB and then
delve into the epidemiology,
which is represented here in this
global burden of extrapulmonary TB.
We'll talk about some of
the reasons in which we see
some geographic differences
in extrapulmonary TB
but again, just how
common presentation of
extrapulmonary TB is in
relation to overall TB cases.
We'll talk about the
diagnostic considerations
and how that may differ in
conventional pulmonary TB,
and then dig into the
clinical presentations
including lymphadenitis,
osteoarticular TB,
gastrointestinal and
genitourinary manifestations,
as well as the morbid conditions
of TB meningitis and CNS TB.
Then I'll finish briefly with
therapeutic
considerations, again,
mostly the subtle
differences between
the treatment of pulmonary
TB and extrapulmonary TB.
1:28
Let's begin with a
representative case.
1:32
This is a 55 year-old man who's a
farmer living in rural Tanzania,
who presented to Haydom
Lutheran Hospital,
who had the good fortune
to care for him there.
He has been keeping cows
and goats for the most part
and has never really been to the
hospital throughout his life.
He does recall though that
he has family members
that have been treated
for TB in the past.
He has a wife and children
and they're all healthy,
but his main reason for presentation
is that he is incontinent of urine.
After further questioning,
it is found out that he has been
having night sweats for six months.
He is now walking hunched over
because of pain in his back
and changes in the way that his
spine has curved and changed,
and that has led to additional
numbness and weakness in his legs.
When you see him, he
is febrile but does
have pretty significant point
tenderness over his mid-back
and then presents with this obvious
gibbus deformity of the upper back.